Minerva Neurosciences Reports Third Quarter 2017 Financial Results and Business Updates WALTHAM, Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...

Health Insurance Innovations, Inc. Reports Record Third Quarter 2017 Financial and Operating Results Increases 2017 Full Year GuidanceRecord Revenues of $63.3 million, up 37% YOYDiluted Earnings per Share of $0.30, up 20% YOYAdjusted Earnings per Share of $0.46, up 39% YOYPolicies in Force totaled...